Despite the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in African Americans, the disorder maybe often overlooked as a diagnosis in the absence of overt signs of hemolysis in neonates with hyperbilirubinemia. We present a case report of anemia and prolonged hyperbilirubinemia due to G6PD deficiency in the absence of hemolysis in dichorionic, triamniotic, preterm triplets of African-American descent.
Introduction
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an X-linked enzymatic disorder, affects many people worldwide, especially within the African, Mediterranean, Kurdish, and Asian populations. Two recent case reports have illustrated the need to consider this disorder in the differential diagnosis of unexplained and prolonged hyperbilirubinemia in African Americans, 1, 2 where the disease frequency is estimated to be around 11-13%. 3 We present a case of progressive early anemia in the absence of indices usually associated with hemolysis and prolonged hyperbilirubinemia due to G6PD deficiency in spontaneous dichorionic, triamniotic, preterm triplets of African-American descent to further heighten awareness of this problem in this at-risk population group.
Case report
The triplet set was born to a 25-year-old gravida 5 para 2 mother of African-Caribbean descent. The pregnancy course was complicated by the diagnosis of a spontaneous dichorionic/triamniotic triplet pregnancy. The mother developed preterm labor at 26 weeks and was given a single course of celestone to enhance fetal pulmonary maturity. At 31 weeks, she again went into preterm labor and the infants were delivered via a cesarean section. The mother's hemoglobin and hematocrit concentrations at the time of delivery were 8.4 g/dl and 27%, respectively. The mother's serologies were unremarkable. Her blood type was B þ . There was no family history of G6PD deficiency or a hemoglobinopathy.
Infants' clinical course
Triplet A was a 1470 g male with Apgar scores of 9 and 9 at 1 and 5 min, respectively. He and the triplet B were considered to be of a monochorionic, diamniotic twin set. Triplet B was a 1430 g male with Apgar scores of 8 and 8 at 1 and 5 min, respectively. Triplet C was a 1545 g singleton male with Apgar scores of 8 and 8 at 1 and 5 min, respectively.
The triplets' clinical courses were similar and are presented next. They exhibited mild respiratory distress, treated with continuous positive airway pressure, and apnea of prematurity, treated with caffeine. Blood cultures were negative. T4/TSH levels were normal. The stool patterns were considered normal for their age. The infants received total parenteral nutrition for approximately the first 10 days and were fed breast milk and formula thereafter.
Their blood types were all B þ and direct Coombs tests were negative. The peripheral blood smears were unremarkable. The infants' hemoglobin, hematocrit, reticulocyte, and total serum bilirubin (TSB) levels, as well as phototherapy treatments are shown in Tables 1-3 . G6PD enzyme activity was undetectable using a qualitative dye reduction method. 4 Genotyping was not performed. Triplet A was started on erythropoietin on DOL 24 for a hemoglobin level of 8.8 g/dl and a hematocrit of 26%. Triplet B received a packed red blood cell transfusion on DOL 16. Notably, Triplet B had a TSB of 17.8 mg/dl on DOL 3. The possibility of an exchange transfusion was considered; however, because the TSB had decreased by 50% within 12 h with intense phototherapy, this was not necessary. Moreover, because the subsequent bilirubin levels were relatively constant, it raised the possibility that the high level may have represented a spurious value. Triplet C had a low mean corpuscular volume at birth (82.2 fL) and remained so till discharge. Barts hemoglobin was not detected.
Discussion
Neonatal jaundice is a manifestation of increased bilirubin production, decreased bilirubin elimination, or a combination of both. Untreated hyperbilirubinemia can lead to encephalopathy and eventually progresses to kernicterus. 5 Normally, bilirubin rises and peaks in the preterm infant on approximately the fifth postnatal day, and then gradually falls over the subsequent several days. An early, rapid rise in bilirubin of greater than 0.2 mg/dl/h raises the possibility of a hemolytic process. In addition to enhanced enterohepatic circulation, G6PD deficiency should also always be considered in infants with an early unexplained rate of rise in bilirubin and/or prolonged jaundice.
The triplet set in this report presented with progressive anemia in the absence of indices usually associated with hemolysis in older patients, that is, a low reticulocyte count and a normal peripheral blood smear and prolonged jaundice. Although the bilirubin levels were not excessively high, in general, in our unit, the bilirubin level has fallen below 10 mg/dl by the end of the first week in infants of this gestational age. There were no major blood group incompatibilities, the direct Coombs tests were negative, and reticulocyte counts were low. The triplets were not exposed to any known oxidizing agents. There was no evidence of infection at any point during their hospital course. Thus, the cause of the progressive anemia remains unclear. Indeed, there has been much 
Treatment with phototherapy is indicated with a+. Note the progressive fall in Hgb/Hct and the prolonged hyperbilirubinemia. Note also the normal reticulocyte counts.
G6PD deficiency in triplets of African-American descent HK Turbendian and JM Perlman debate as to the etiology of hyperbilirubinemia in G6PD deficient neonates in the absence of precipitating factors. Dhillon et al. 6 reported marked acute hemolysis in three G6PD deficient neonates (including a set of twins) that could not be attributed to any blood group incompatibilities, exposure to oxidizing agents, or infection. Although other studies have detected the presence of hemolysis in G6PD deficient neonates, the authors have suggested that it may not be the causative factor in the development of jaundice.
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Kaplan has suggested that the antioxidant response of G6PD deficient neonatal red blood cells may be unable to contend with naturally occurring oxidants, and that this may be a partial explanation for hemolysis in the absence of exogenous oxidizing agents.
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A defect in bilirubin elimination is considered to be the most likely explanation for hyperbilirubinemia. 12 Some reports attribute hyperbilirubinemia to the immaturity of the uridine diphosphate glucuronosyltransferase (UGT) 1A1 enzyme system, which is responsible for bilirubin conjugation. 13, 14 Kaplan et al. 15 found that, within the G6PD deficient population, infants heterozygous for a variant UGT1A1 promoter had a 32% incidence of hyperbilirubinemia, and homozygotes had an incidence of 50%. They also observed that neither G6PD deficiency nor UGT1A1 mutations alone increase the occurrence of hyperbilirubinemia. Huang et al. 16 found a similar increased risk of hyperbilirubinemia in G6PD deficient Taiwanese infants homozygous for a UGT1A1 variant. The most frequent UGT1A1 promoter variant is reported to affect up to 36% of Africans. 17 This suggests the possibility of a multigenic disease where a deficient UGT1A1 enzyme system is unable to contend with increased bilirubin from clinically undetected hemolysis related to the G6PD deficiency.
Infants of high-risk population groups can develop acute hemolytic crises with severe hyperbilirubinemia. This case report demonstrates a rare instance of G6PD deficiency in a set of spontaneous, diamniotic, trichorionic, preterm triplets. It serves as a reminder to consider this enzymatic disorder even in the absence of indices usually associated with hemolysis, when dealing with persistent hyperbilirubinemia in neonates, including preterms, whose ethnic background may render them more likely to be afflicted.
